Vice President, Medical Affairs
Recursion
2 days ago
Remote friendly (New York, NY)
United States
Medical Affairs
Vice President, Medical Affairs
In this role, you will:
- Develop and lead integrated Medical Affairs strategies for priority assets (scientific narrative, evidence gaps, stakeholder engagement, publication strategy, medical education, advisory boards, field medical planning, launch readiness).
- Support cross-functional asset teams with Clinical Development, Regulatory Affairs, Development Sciences, HEOR/RWE, Biostatistics, Clinical Operations, Portfolio Strategy, Patient Advocacy, Communications, Legal/Compliance, and Business Development.
- Build evidence-generation plans (RWE, HEOR, epidemiology, natural history, burden of disease, treatment patterns, outcomes/value-focused studies).
- Translate external insights from healthcare professionals, investigators, patient communities, payers, and health systems into recommendations for development strategy, trial design/endpoints, education needs, and evidence priorities.
- Lead compliant scientific engagement with KOLs, investigators, cooperative groups, patient advocacy organizations, and professional societies.
- Lead congress/conference strategy (ASCO, ESMO, AACR, AAN, etc.), including abstracts, presentations, medical booths, and KOL engagement.
- Partner with data/Decision Science teams on responsible AI-enabled medical insights and evidence synthesis.
- Establish medical communication strategy (publications, congress content, lexicon, scientific platform, FAQs, medical information, internal training).
- Build a scalable Medical Affairs organization and establish governance, operating rhythms, vendor partnerships, performance metrics, and compliant processes.
Qualifications/experience:
- Advanced clinical/scientific degree required; MD/DO/PharmD/PhD or equivalent strongly preferred.
- 15+ years biotech/pharma experience with significant Medical Affairs leadership.
- Experience leading Medical Affairs strategy for clinical/launch-stage assets (ideally oncology, rare disease, immunology, or specialty areas).
- Proven integrated evidence planning (RWE/HEOR/epidemiology/burden/natural history/treatment patterns/outcomes/value studies).
- Strong understanding of drug development lifecycle and Medical Affairs contribution to trial design, endpoints, engagement, publications, and evidence generation.
- Demonstrated compliant engagement with KOLs, investigators, patient advocacy, societies, payers/HTA.
- Experience with scientific platforms, publication plans, congress strategies, advisory boards, medical education, and medical information resources.
- Strong working knowledge of compliance expectations for scientific exchange, medical review, publication practices, and advisory board governance.
Benefits/compensation:
- Estimated annual base range: $358,930–$449,240 (USD), plus annual bonus, equity compensation, and comprehensive benefits.
Working location:
- Hybrid; NYC office at least 50% of the time.
In this role, you will:
- Develop and lead integrated Medical Affairs strategies for priority assets (scientific narrative, evidence gaps, stakeholder engagement, publication strategy, medical education, advisory boards, field medical planning, launch readiness).
- Support cross-functional asset teams with Clinical Development, Regulatory Affairs, Development Sciences, HEOR/RWE, Biostatistics, Clinical Operations, Portfolio Strategy, Patient Advocacy, Communications, Legal/Compliance, and Business Development.
- Build evidence-generation plans (RWE, HEOR, epidemiology, natural history, burden of disease, treatment patterns, outcomes/value-focused studies).
- Translate external insights from healthcare professionals, investigators, patient communities, payers, and health systems into recommendations for development strategy, trial design/endpoints, education needs, and evidence priorities.
- Lead compliant scientific engagement with KOLs, investigators, cooperative groups, patient advocacy organizations, and professional societies.
- Lead congress/conference strategy (ASCO, ESMO, AACR, AAN, etc.), including abstracts, presentations, medical booths, and KOL engagement.
- Partner with data/Decision Science teams on responsible AI-enabled medical insights and evidence synthesis.
- Establish medical communication strategy (publications, congress content, lexicon, scientific platform, FAQs, medical information, internal training).
- Build a scalable Medical Affairs organization and establish governance, operating rhythms, vendor partnerships, performance metrics, and compliant processes.
Qualifications/experience:
- Advanced clinical/scientific degree required; MD/DO/PharmD/PhD or equivalent strongly preferred.
- 15+ years biotech/pharma experience with significant Medical Affairs leadership.
- Experience leading Medical Affairs strategy for clinical/launch-stage assets (ideally oncology, rare disease, immunology, or specialty areas).
- Proven integrated evidence planning (RWE/HEOR/epidemiology/burden/natural history/treatment patterns/outcomes/value studies).
- Strong understanding of drug development lifecycle and Medical Affairs contribution to trial design, endpoints, engagement, publications, and evidence generation.
- Demonstrated compliant engagement with KOLs, investigators, patient advocacy, societies, payers/HTA.
- Experience with scientific platforms, publication plans, congress strategies, advisory boards, medical education, and medical information resources.
- Strong working knowledge of compliance expectations for scientific exchange, medical review, publication practices, and advisory board governance.
Benefits/compensation:
- Estimated annual base range: $358,930–$449,240 (USD), plus annual bonus, equity compensation, and comprehensive benefits.
Working location:
- Hybrid; NYC office at least 50% of the time.